Literature DB >> 16885027

Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase.

Maojun Yang1, Christian B Gocke, Xuelian Luo, Dominika Borek, Diana R Tomchick, Mischa Machius, Zbyszek Otwinowski, Hongtao Yu.   

Abstract

Histone methylation regulates diverse chromatin-templated processes, including transcription. Many transcriptional corepressor complexes contain lysine-specific demethylase 1 (LSD1) and CoREST that collaborate to demethylate mono- and dimethylated H3-K4 of nucleosomes. Here, we report the crystal structure of the LSD1-CoREST complex. LSD1-CoREST forms an elongated structure with a long stalk connecting the catalytic domain of LSD1 and the CoREST SANT2 domain. LSD1 recognizes a large segment of the H3 tail through a deep, negatively charged pocket at the active site and possibly a shallow groove on its surface. CoREST SANT2 interacts with DNA. Disruption of the SANT2-DNA interaction diminishes CoREST-dependent demethylation of nucleosomes by LSD1. The shape and dimension of LSD1-CoREST suggest its bivalent binding to nucleosomes, allowing efficient H3-K4 demethylation. This spatially separated, multivalent nucleosome binding mode may apply to other chromatin-modifying enzymes that generally contain multiple nucleosome binding modules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885027     DOI: 10.1016/j.molcel.2006.07.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  144 in total

Review 1.  Structural insights into histone lysine demethylation.

Authors:  Haifeng Hou; Hongtao Yu
Journal:  Curr Opin Struct Biol       Date:  2010-10-21       Impact factor: 6.809

Review 2.  Molecular mechanisms and potential functions of histone demethylases.

Authors:  Susanne Marije Kooistra; Kristian Helin
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

3.  Histone demethylases and their roles in cancer epigenetics.

Authors:  Alexandra D'Oto; Qing-Wu Tian; Andrew M Davidoff; Jun Yang
Journal:  J Med Oncol Ther       Date:  2016

Review 4.  Signaling and epigenetic regulation of pituitary development.

Authors:  Xiaoyan Zhu; Jianxun Wang; Bong-Gun Ju; Michael G Rosenfeld
Journal:  Curr Opin Cell Biol       Date:  2007-11-07       Impact factor: 8.382

Review 5.  Multivalent engagement of chromatin modifications by linked binding modules.

Authors:  Alexander J Ruthenburg; Haitao Li; Dinshaw J Patel; C David Allis
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 6.  LSD1 and the chemistry of histone demethylation.

Authors:  Jeffrey C Culhane; Philip A Cole
Journal:  Curr Opin Chem Biol       Date:  2007-09-11       Impact factor: 8.822

7.  Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation.

Authors:  Ning Ding; Haiying Zhou; Pierre-Olivier Esteve; Hang Gyeong Chin; Seokjoong Kim; Xuan Xu; Sumy M Joseph; Michael J Friez; Charles E Schwartz; Sriharsa Pradhan; Thomas G Boyer
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

8.  Control of neuronal differentiation by sumoylation of BRAF35, a subunit of the LSD1-CoREST histone demethylase complex.

Authors:  María Ceballos-Chávez; Sabrina Rivero; Pablo García-Gutiérrez; Manuel Rodríguez-Paredes; Mario García-Domínguez; Shomi Bhattacharya; José C Reyes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-08       Impact factor: 11.205

9.  Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.

Authors:  Martin L Schmitt; Alexander-Thomas Hauser; Luca Carlino; Martin Pippel; Johannes Schulz-Fincke; Eric Metzger; Dominica Willmann; Teresa Yiu; Michelle Barton; Roland Schüle; Wolfgang Sippl; Manfred Jung
Journal:  J Med Chem       Date:  2013-09-05       Impact factor: 7.446

10.  Profiling RE1/REST-mediated histone modifications in the human genome.

Authors:  Deyou Zheng; Keji Zhao; Mark F Mehler
Journal:  Genome Biol       Date:  2009-01-27       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.